Raju Mukherjee's Lab

Molecular Microbiology Lab @IiserTirupati
#TB #Mycomembrane #Antibiotic_tolerance
We employ TnSeq & LC-MS proteomics to unravel mycobacterial mysteries

[Ana Marcia Guimaraes @AnaMarciaSG]

Methylglyoxal is an antibacterial effector produced by macrophages during infection | bioRxiv https://t.co/j8KIJaoUki

[Valerie Mizrahi @ValerieMizrahi]

Tuberculosis resurges as top infectious disease killer https://t.co/2MS2lHpwFk

[Ana Marcia Guimaraes @AnaMarciaSG]

Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus https://t.co/Ce62HuLsgE

[Raju Mukherjee's Lab @RMLab3]

@H3D_Foundation @Kelly_Chibale @theNAMedicine Congratulations @Kelly_Chibale! Well deserved!

[Raju Mukherjee's Lab @RMLab3]

We are excited to organise this EMBO Satellite Symposia on "Infection Biology at IISER Tirupati, India. Prolific speakers will share and discuss great science happening at the frontiers of infection biology!
Pls join us, register and RT!
@IiserTirupati @EMBO @CNRS

[TB Alliance @TBAlliance]

Drug-resistant #TB continues to challenge global health systems. By investing in innovative research and development, we can ensure no one is left behind. #EndTB #AMRAction

[Kremer Laurent @KremerLaurent1]

Excited to share our last work regarding the characterization of a dTDP-L-Rhamnose 4-epimerase required for glycopeptidolipid biosynthesis in mycobacteria. Thanks to the @GuerardelY, @WilmannsGroup, @jl_herrmann, @canaanLab, K Nakajima and L Wen teams.
https://t.co/477TGQEVwG

[Raju Mukherjee's Lab @RMLab3]

@ONeyrolles @TejanL @eLife @IiserTirupati @CSIR_IND @DBTIndia @EMBO @AseemPalande @gLarrouyM_Lab @danybeste Thank you @ONeyrolles !!

[Raju Mukherjee's Lab @RMLab3]

Excited to share Tejan's @TejanL PhD thesis work published in @eLife https://t.co/yxRVzLq0pU
Grateful to @IiserTirupati @CSIR_IND @DBTIndia @EMBO for funding.
Fun working with @AseemPalande @gLarrouyM_Lab @danybeste
Great collaboration & pleasure working with @danybeste Pls RT!

[Raju Mukherjee's Lab @RMLab3]

@Rachit_AgarwaI @TejanL @eLife @IiserTirupati @CSIR_IND @DBTIndia @EMBO @AseemPalande @gLarrouyM_Lab @danybeste Thank you @Rachit_AgarwaI for your wishes and valuable comments!

[Raju Mukherjee's Lab @RMLab3]

@Ramande39667129 @danybeste @TejanL @eLife Thank you @Ramande39667129 !!

[Raju Mukherjee's Lab @RMLab3]

@RanjanN2022 @danybeste @TejanL @eLife Thank you so much!

[Raju Mukherjee's Lab @RMLab3]

@danybeste @TejanL @eLife Thank you Dany!! It was pleasure working with you!

[Dhiraj kumar @dhirajverma]

A new axis of pathogenicity in #tuberculosis involving #neutrophils and a strategy to improve TB prevention and control!
@ICGEBNewDelhi @DBTIndia @Lab_AmitSinghal
https://t.co/vFnubZhz7v @eLife

[TB Alliance @TBAlliance]

After years of complacency, the world is waking up to TB's deadly toll. A new vaccine could prevent millions of cases and save countless lives. Find out more in an article from @Telegraph https://t.co/xy7x2mgyaK #EndTB #GlobalHealth

[G Kang @GKangInd]

AMR is being highlighted at the UN General Assembly. We know how devastating drug resistant infections can be for individuals and communities. 👇https://t.co/BT3wPIfhEC

[Pierre SANTUCCI @PSantTB]

⚠️ Happy to share our latest preprint on the pH dependent activity of salicylic acid derivatives against M.tuberculosis 🦠🧫🔬🤓

Very cool team work with the one and only @JefCavalier @canaanlab @LISM_CNRS_AMU & @ULBruxelles 👇👇👇

[Raju Mukherjee's Lab @RMLab3]

Our lab has an opening for a postdoc position on understanding antibiotic tolerance in M. tuberculosis
Info & Apply @ https://t.co/y8BV5vZQvG
Pls reach out to [email protected] for more information
For Indian nationals only

[Amit Singhal @Lab_AmitSinghal]

Few additions:
- Only student/trainie registration (INR 12,000) include sharing basis accomodation 🙂.
- Travel and Child care grants from @EMBO
- Flights from many major destinatins in Asia, EU, and US. Best connection by SQ, AirFrance and Emirates.

[anil_ojha @Anil_Ojha1]

NTM conference @ Colorado State Is happening again in 2025! Topics range from basic research on host and bacteria to diagnosis and therapy. Yes, phage therapy included. Registration opens Dec. 1 https://t.co/R5QPmIfszy